STAT3 contributes to cisplatin resistance, modulating EMT markers, and the mTOR signaling in lung adenocarcinoma. - Morelli AP; Tortelli TC Jr; Mancini MCS; Pavan ICB; Silva LGS; Severino MB; Granato DC; Pestana NF; Ponte LGS; Peruca GF; Pauletti BA; Dos Santos DFG Jr; et al. (Neoplasia (New York, N.Y.), 2021)